We examine the problem of overcharging extremal and near-extremal black hole solutions of Einstein-Gauss-Bonnet gravity in any dimension, generalizing the result in general relativity. We show that as in the case of general relativity, it is not possible to create a naked singularity by overcharging an extremal black hole in Einstein-Gauss-Bonnet gravity using a charged test particle. Our result suggests that the validity of the cosmic censorship hypothesis transcends beyond general relativity to well motivated higher curvature gravity.
Classifying consistent effective field theories for the gravitational interaction has recently been the subject of intense research. Demanding the absence of causality violation in high energy graviton scattering processes has led to a hierarchy of constraints on higher derivative terms in the Lagrangian. Most of these constraints have relied on analysis that is performed in general relativistic backgrounds, as opposed to a generic solution to the equations of motion which are perturbed by higher curvature operators. Hence, these constraints are necessary but may not be sufficient to ensure that the theory is consistent. In this context, we explore the so-called CEMZ causality constraints on Quadratic Gravity in a space of shock wave solutions beyond GR. We show that the Shapiro time delay experienced by a graviton is polarization-independent and positive, regardless of the strength of the gravitational couplings. Our analysis shows that as far as the causality constraints are concerned, albeit inequivalent to General Relativity due to additional propagating modes, Quadratic Gravity is causal as per as the diagnostic proposed by CEMZ.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.